Trial Profile
A retrospective study to evaluate the efficacy of adalimumab in naive patients used after previous TNFa blocker failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Aug 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary)
- Indications Psoriasis
- Focus Therapeutic Use
- 24 Aug 2015 New trial record